DUMAC Inc’s Transmedics TMDX Stock Holding History

DUMAC Inc’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,753	Closed	-$275K	–	18
2022 Q2	$275K	Buy	+8,753	New	+$233K	0.98%	12

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

DUMAC Inc's TMDX Position: Q3 2022 in Review

DUMAC Inc sold out of Transmedics (TMDX) in Q3 2022, closing a stake of 8,753 shares — an estimated $275K sold.

DUMAC Inc first reported a position in TMDX in Q2 2022 and held it in 1 quarter. The position peaked at $275K in Q2 2022. 178 funds tracked by Wall St. Rank hold TMDX as of Q3 2022.

DUMAC Inc reported no remaining Transmedics position as of Q3 2022 after selling out during the quarter.
DUMAC Inc sold 8,753 Transmedics shares in Q3 2022, an estimated $275K.
DUMAC Inc first reported a position in Transmedics in Q2 2022 and held it in 1 quarter.
DUMAC Inc's Transmedics position peaked at $275K in Q2 2022.
178 funds tracked by Wall St. Rank held Transmedics as of Q3 2022.

Based on DUMAC Inc's 13F filing for Q3 2022, filed 14 Nov 2022.